₹6,309.9 crore released to States, Union Territories: Centre
Tamil Nadu has been provided ₹773.24 crore in financial support under the India COVID-19 Emergency Response and Health Systems Preparedness Package, according to information provided in the Rajya Sabha on Tuesday.
Under the package, ₹6,309.9 crore had been released to the States and the Union Territories, through the National Health Mission as on January 15.
Minister of State for Health and Family Welfare Ashwini Kumar Choubey said this in a written reply to questions about the COVID-19 assistance that was provided to the States.
In all, 18.66 lakh N-95 masks and 5.39 lakh PPE kits had been procured centrally and distributed in Tamil Nadu. Besides, 3,625 oxygen cylinders had been distributed in the State as on January 24.
Harsh Vardhan unveils IEC campaign to address vaccine hesitancy ANI | Updated: Jan 21, 2021 20:10 IST
New Delhi [India], January 21 (ANI): To address the emerging issue of vaccine hesitancy in some sections of the population in the country, Union Minister of Health and Family Welfare Dr Harsh Vardhan, unveiled IEC posters on Thursday.
The world s largest immunisation exercise against COVID-19 was launched by Prime Minister Narendra Modi on January 16, 2021, and according to official data, more than 8 lakh healthcare workers have been vaccinated till 7 am on January 21, 2021.
As per an official release, the Union Health Minister reminded everyone of the achievements of the country, the second-most populous country in the world.
New Delhi [India], January 3 (ANI): With COVID-19 vaccines of Serum Institue of India and Bharat Biotech being granted permission for restricted use in an emergency situation, Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey on Sunday stated that India will become corona-free.
The Serum Institute of India, which is manufacturing and testing Oxford/AstraZeneca’s coronavirus vaccine in the country, said on Monday it expected regulatory approval for the shot in a few days. Serum’s Chief Executive Adar Poonawalla said the vaccine, named Covishield in India, should be licensed by January.
“The emergency use authorisation by the UK drug regulator for the Oxford-AstraZeneca vaccine against Covid-19 is expected by December end or first week of January. In India too, we are hoping for regulatory approval for the Covishield vaccine in a few days. We must respect the process and give the drug regulators in the UK and India enough time to review the data. No one wants to compromise on safety and we hope for some good news in the new year,” Poonawalla said.